Overview

Oral Ivermectin for Chikungunya Viral Infection

Status:
COMPLETED
Trial end date:
2024-01-26
Target enrollment:
Participant gender:
Summary
Chikungunya viral infection (CVI) is a mosquito-borne infection, caused by chikungunya virus (CHIKV), an alphavirus, belonging to the family Togaviridae. This infection causes febrile illness associated with high fever, rash, acute deliberating and persistent arthralgia. There is no licensed vaccine or specific treatment for this infection. Ivermectin (IVM), commonly-used antiparasitic, has been demonstrated to inhibit replication of CHIKV.
Phase:
PHASE3
Details
Lead Sponsor:
Prince of Songkla University
Treatments:
Ivermectin